Literature DB >> 2344862

Agranulocytosis induced by cinepazide.

J R Laporte1, D Capellà, J Juan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2344862     DOI： 10.1007/bf00315580

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  4 in total

1.  [Agranulocytosis caused by cinepazide maleate. 2 case reports].

Authors:  F Chague; C Sgro; D Caillot; H Guy; C Portier; P Louis; A Escousse
Journal:  Therapie       Date:  1987 Jan-Feb       Impact factor: 2.070

2.  Aprindine and agranulocytosis.

Authors:  L H Opie
Journal:  Lancet       Date:  1980-09-27       Impact factor: 79.321

3.  Blood dyscrasias and the relative safety of non-narcotic analgesics.

Authors:  J R Laporte; X Carné
Journal:  Lancet       Date:  1987-04-04       Impact factor: 79.321

4.  Risks of agranulocytosis and aplastic anemia. A first report of their relation to drug use with special reference to analgesics. The International Agranulocytosis and Aplastic Anemia Study.

Authors: 
Journal:  JAMA       Date:  1986-10-03       Impact factor: 56.272
  4 in total
  6 in total

Review 1.  Case-population studies in pharmacoepidemiology.

Authors:  Dolors Capellà; Consuelo Pedrós; Xavier Vidal; Joan-Ramon Laporte
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

2.  Detection and incidence of drug-induced agranulocytosis in hospital: a prospective analysis from laboratory signals.

Authors:  N Tavassoli; E Duchayne; B Sadaba; K Desboeuf; A Sommet; M Lapeyre-Mestre; M J Muoz; P Sie; J Honorato; J L Montastruc; H Bagheri
Journal:  Eur J Clin Pharmacol       Date:  2007-01-17       Impact factor: 2.953

3.  Adverse drug reactions leading to hospital admission.

Authors:  L Ibáñez; J R Laporte; X Carné
Journal:  Drug Saf       Date:  1991 Nov-Dec       Impact factor: 5.606

4.  The case-population study design: an analysis of its application in pharmacovigilance.

Authors:  Hélène Théophile; Joan-Ramon Laporte; Nicholas Moore; Karin-Latry Martin; Bernard Bégaud
Journal:  Drug Saf       Date:  2011-10-01       Impact factor: 5.606

5.  Agranulocytosis associated with dipyrone (metamizol).

Authors:  Luisa Ibáñez; Xavier Vidal; Elena Ballarín; Joan-Ramon Laporte
Journal:  Eur J Clin Pharmacol       Date:  2004-12-03       Impact factor: 2.953

6.  Possible association between ocular chloramphenicol and aplastic anaemia--the absolute risk is very low.

Authors:  J R Laporte; X Vidal; E Ballarín; L Ibáñez
Journal:  Br J Clin Pharmacol       Date:  1998-08       Impact factor: 4.335
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.